# Central Nervous System (CNS) Agents: Movement Disorders

## LENGTH OF AUTHORIZATIONS

365 Days

## PRIOR AUTHORIZATION CRITERIA

Is there any reason the patient cannot be changed to a medication not requiring prior approval?

Acceptable reasons include:

- Allergy to all medications not requiring prior approval

- Contraindication to or drug-to-drug interaction with medications not requiring prior approval.

- History of unacceptable/toxic side effects to medications not requiring prior approval

## ADDITIONAL CRITERIA FOR THE TREATMENT OF TARDIVE DYSKINESIA

- Prescribed by a Neurologist or Psychiatrist

- Ingrezza is ONLY indicated for the treatment of Tardive Dyskinesia

## ADDITIONAL CRITERIA FOR AUSTEDO FOR THE TREATMENT OF HUNTINGTONâ€™S DISEASE

- The patient must have a failure to respond to maximally tolerated dose of tetrabenazine

Austedo quantity limit of 4 tablets per day

## Movement Disorders

Central Nervous System (CNS) Agents: Movement Disorders

| PREFERRED | NON-PREFERRED |
| :--- | ---: |
| Austedo PA QL    | |
| Ingrezza PA      | |
| Tetrabenazine PA | |

### Link to Criteria

[Central Nervous System (CNS) Agents: Movement Disorders](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=36)
